|
|
|
|
Site networks that work with community and trial-naïve sites are changing the perception of what a trial site should look like and where it should be located. In turn they are then able to provide sponsors with access to patient groups underrepresented in the clinical research space, give sites the support they need to thrive in clinical research, and expand healthcare access into countries and communities, globally.
|
|
|
|
|
The progressive nature of ALS often limits mobility, making regular travel to clinical sites physically exhausting or outright impossible. This case study examines how Home Trial Support (HTS) services can play a pivotal role in addressing these barriers, enhancing accessibility and participation in ALS trials.
|
|
|
|
|
Technology in decentralized clinical trials can offer infinite possibilities when it comes to connecting patients with trials. Learn how this powerful tool, when used correctly, can accelerate trial timelines and drive patient diversification in community-based, DCTs.
|
|
|
|
|
Effective Home Trial Support (HTS) solutions have the capability to support patients, enhance trial recruitment and alleviate site burdens. By reaching into the heart of communities, Home Trial Support plays an invaluable role in driving the development of lifesaving, representative, medicines and therapies.
|
|
|
|
|
|
|
|
MRN Will Be At OCT EU This April!
|
MRN is driving expansion in clinical trial reach and bringing participation opportunities to new patients by working with new sites, in new communities. Meet with the MRN Team at the 25th annual Outsourcing in Clinical Trials EU conference, and learn how we can work with you to increase patient enrollment and engagement, accelerating your trial timelines. Schedule a meeting time and visit us at Booth #61.
|
|
|
